The global pharmaceutical sector has undergone enormous changes in the past 10 years and stands at a cusp of an inflection point given the speed at which R&D is going on today. Moreover, the digital ecosystem has challenged traditional models and on-going digitization initiatives aim to expand collaboration and new businesses at breakneck speeds. It is predicted that by 2021, 50% of pharmaceutical and biotech companies will use IOT data and build predictive analytics models coupled with AI to optimize their supply chain by over 30%. According to Gartner, by 2025, it is estimated that about 150 Zetabytes (150 Trillion Gigabytes) of data will be analyzed by the entire pharma industry. This enormous growth and reliance on data for insights indicates that data management and analytics would be key to organizational survival & success going forward.
Intelliswift helps pharma companies realize this value by identifying and implementing data strategies and technologies in their commercial operations. We are the chosen service provider to enable new growth drivers for our clients, as we provide them with industry-leading best practices while taking care of their compliance needs.
Intelliswift Data Management-as-a-Service (DMaaS) is a technology and cloud-based managed service that...Read More